BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34909713)

  • 1. Unlocking the Mechanisms of Cutaneous Adverse Drug Reactions: Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway by EGFR Inhibitors Triggers Keratinocyte Differentiation and Polarization of Epidermal Immune Responses.
    Ondet T; Roux PF; Monshouwer M; Stamatas GN
    JID Innov; 2021 Jun; 1(2):100009. PubMed ID: 34909713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function.
    Joly-Tonetti N; Ondet T; Monshouwer M; Stamatas GN
    BMC Cancer; 2021 Jan; 21(1):5. PubMed ID: 33402117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of kinin B receptor triggers differentiation of cultured human keratinocytes.
    Matus CE; Ehrenfeld P; Pavicic F; Sarmiento JM; Astroza A; Sanchez T; Salem C; Concha M; Vidal MA; Gonzalez CB; Figueroa CD
    Br J Dermatol; 2008 Sep; 159(4):792-803. PubMed ID: 18717683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway.
    Jost M; Huggett TM; Kari C; Boise LH; Rodeck U
    J Biol Chem; 2001 Mar; 276(9):6320-6. PubMed ID: 11098053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.
    Coco S; Truini A; Alama A; Dal Bello MG; Venè R; Garuti A; Carminati E; Rijavec E; Genova C; Barletta G; Sini C; Ballestrero A; Boccardo F; Grossi F
    Target Oncol; 2015 Sep; 10(3):393-404. PubMed ID: 25341405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor.
    El-Abaseri TB; Putta S; Hansen LA
    Carcinogenesis; 2006 Feb; 27(2):225-31. PubMed ID: 16123117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation.
    Peus D; Hamacher L; Pittelkow MR
    J Invest Dermatol; 1997 Dec; 109(6):751-6. PubMed ID: 9406816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer.
    Liu C; Shaurova T; Shoemaker S; Petkovich M; Hershberger PA; Wu Y
    Mol Pharm; 2018 Aug; 15(8):3216-3226. PubMed ID: 29902012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23.
    Wu W; Fan H; Jiang Y; Liao L; Li L; Zhao J; Zhang H; Shrestha C; Xie Z
    Exp Dermatol; 2018 Nov; 27(11):1201-1209. PubMed ID: 30066343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
    Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
    J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of cell signaling in a reconstructed human epidermis exposed to sensitizers: IL-8 synthesis and release depend on EGFR activation.
    Frankart A; Coquette A; Schroeder KR; Poumay Y
    Arch Dermatol Res; 2012 May; 304(4):289-303. PubMed ID: 22271211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer.
    Yonesaka K; Kudo K; Nishida S; Takahama T; Iwasa T; Yoshida T; Tanaka K; Takeda M; Kaneda H; Okamoto I; Nishio K; Nakagawa K
    Oncotarget; 2015 Oct; 6(32):33602-11. PubMed ID: 26418897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal keratinocytes initiate wound healing and pro-inflammatory immune responses following percutaneous schistosome infection.
    Bourke CD; Prendergast CT; Sanin DE; Oulton TE; Hall RJ; Mountford AP
    Int J Parasitol; 2015 Mar; 45(4):215-24. PubMed ID: 25575749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human catestatin enhances migration and proliferation of normal human epidermal keratinocytes.
    Hoq MI; Niyonsaba F; Ushio H; Aung G; Okumura K; Ogawa H
    J Dermatol Sci; 2011 Nov; 64(2):108-18. PubMed ID: 21872447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between epidermal growth factor receptor and protein kinase C during calcium-induced differentiation of keratinocytes.
    Denning MF; Dlugosz AA; Cheng C; Dempsey PJ; Coffey RJ; Threadgill DW; Magnuson T; Yuspa SH
    Exp Dermatol; 2000 Jun; 9(3):192-9. PubMed ID: 10839717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
    Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staurosporine induces a sequential program of mouse keratinocyte terminal differentiation through activation of PKC isozymes.
    Stanwell C; Denning MF; Rutberg SE; Cheng C; Yuspa SH; Dlugosz AA
    J Invest Dermatol; 1996 Mar; 106(3):482-9. PubMed ID: 8648181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients.
    Wu SG; Liu YN; Tsai MF; Chang YL; Yu CJ; Yang PC; Yang JC; Wen YF; Shih JY
    Oncotarget; 2016 Mar; 7(11):12404-13. PubMed ID: 26862733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of STIM1- and Orai1-mediated Ca2+ entry in Ca2+-induced epidermal keratinocyte differentiation.
    Numaga-Tomita T; Putney JW
    J Cell Sci; 2013 Jan; 126(Pt 2):605-12. PubMed ID: 23203806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two modes of ERK activation by TNF in keratinocytes: different cellular outcomes and bi-directional modulation by vitamin D.
    Ziv E; Rotem C; Miodovnik M; Ravid A; Koren R
    J Cell Biochem; 2008 May; 104(2):606-19. PubMed ID: 18080320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.